Alnylam Pharmaceuticals, Inc.
Compositions and methods for inhibiting expression of TMPRSS6 gene
Last updated:
Abstract:
The invention relates to double-stranded ribonucleic acid (dsRNA) compositions targeting the TMPRSS6 gene, and methods of using such dsRNA compositions to inhibit expression of TMPRSS6.
Status:
Grant
Type:
Utility
Filling date:
4 Sep 2018
Issue date:
14 Dec 2021